---
sidebar_position: 76
---
           <p class="stitle-article-norm">Information from the sponsor at the end of a clinical investigation or in the event of a temporary halt or early termination</p>
   <p class="norm">1.&nbsp;&nbsp;If the sponsor has temporarily halted a
 clinical investigation or has terminated a clinical investigation 
early, it shall inform within 15 days the Member&nbsp;State in which 
that clinical investigation has been temporarily halted or terminated 
early, through the electronic system referred to in <a href='../CHAPTER VI/Article 73 - Electronic system on clinical investigations'> Article 73</a>, of 
the temporary halt or early termination, providing a justification. In 
the event that the sponsor has temporarily halted or terminated early 
the clinical investigation on safety grounds, it shall inform all 
Member&nbsp;States in which that clinical investigation is being 
conducted thereof within 24 hours.</p>
   <p class="norm">2.&nbsp;&nbsp;The end of a clinical investigation 
shall be deemed to coincide with the last visit of the last subject 
unless another point in time for such end is set out in the clinical 
investigation plan.</p>
   <p class="norm">3.&nbsp;&nbsp;The sponsor shall notify each 
Member&nbsp;State in which a clinical investigation was being conducted 
of the end of that clinical investigation in that Member&nbsp;State. 
That notification shall be made within 15 days of the end of the 
clinical investigation in relation to that Member&nbsp;State.</p>
   <p class="norm">4.&nbsp;&nbsp;If an investigation is conducted in 
more than one Member&nbsp;State, the sponsor shall notify all 
Member&nbsp;States in which that clinical investigation was conducted of
 the end of the clinical investigation in all Member&nbsp;States. That 
notification shall be made within 15 days of that end of the clinical 
investigation.</p>
   <p class="norm">5.&nbsp;&nbsp;Irrespective of the outcome of the 
clinical investigation, within one year of the end of the clinical 
investigation or within three months of the early termination or 
temporary halt, the sponsor shall submit to the Member&nbsp;States in 
which a clinical investigation was conducted a clinical investigation 
report as referred to in Section&nbsp;2.8 of Chapter I and 
Section&nbsp;7 of Chapter III of Annex&nbsp;XV.</p>
   <p class="norm">The clinical investigation report shall be 
accompanied by a summary presented in terms that are easily 
understandable to the intended user. Both the report and summary shall 
be submitted by the sponsor by means of the electronic system referred 
to in <a href='../CHAPTER VI/Article 73 - Electronic system on clinical investigations'> Article 73</a>.</p>
   <p class="norm">Where, for scientific reasons, it is not possible to 
submit the clinical investigation report within one year of the end of 
the investigation, it shall be submitted as soon as it is available. In 
such case, the clinical investigation plan referred to in Section&nbsp;3
 of Chapter&nbsp;II of Annex&nbsp;XV shall specify when the results of 
the clinical investigation are going to be available, together with a 
justification.</p>
   <p class="norm">6.&nbsp;&nbsp;The Commission shall issue guidelines 
regarding the content and structure of the summary of the clinical 
investigation report.</p>
   <p class="norm">In addition, the Commission may issue guidelines for 
the formatting and sharing of raw data, for cases where the sponsor 
decides to share raw data on a voluntary basis. Those guidelines may 
take as a basis and adapt, where possible, existing guidelines for 
sharing of raw data in the field of clinical investigations.</p>
   <p class="norm">7.&nbsp;&nbsp;The summary and the clinical 
investigation report referred to in paragraph&nbsp;5 of this 
Article&nbsp;shall become publicly accessible through the electronic 
system referred to in <a href='../CHAPTER VI/Article 73 - Electronic system on clinical investigations'> Article 73</a>, at the latest when the device is 
registered in accordance with <a href='../CHAPTER III/Article 29 - Registration of devices'> Article 29</a> and before it is placed on
 the market. In cases of early termination or temporary halt, the 
summary and the report shall become publicly accessible immediately 
after submission.</p>
   <p class="norm">If the device is not registered in accordance with 
<a href='../CHAPTER III/Article 29 - Registration of devices'> Article 29</a> within one year of the summary and the report having 
been entered into the electronic system pursuant to paragraph&nbsp;5 of 
this Article, they shall become publicly accessible at that point in 
time.</p>